Healthtech Growth Investors & VC Firms
1213 firms in this list, with a median first check of $1.1M. 281 of them lead rounds. Generated from verified public data and updated continuously.
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
8 people
Waterline Ventures
CambridgeSeries A–Growth
11 people
Kama Flow
MoscowSeed–Late Stage
2 people
Averin Capital
New YorkSeed–Growth
9 people
Cure Kids Ventures
AucklandSeed–Growth
6 people
HongShan Capital Group
Hong KongPre-Seed–Late Stage
Kinnevik
StockholmSeed–Late Stage
Pivotal bioVenture Partners
San FranciscoSeed–Late Stage
12 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
8 people
Season Two Ventures
OrangeSeed–Growth
8 people
20/20 HealthCare Partners LLC
AuburndaleSeed–Late Stage
7 people
Angelini Ventures
RomeSeed–Growth
4 people
Invest Tech
São PauloPre-Seed–Late Stage
4 people
Tana Africa Capital
JohannesburgGrowth–Late Stage
10 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
Clearspring Capital Partners
TorontoGrowth–Late Stage
12 people
Kintetsu Venture Partners
Seed–Growth
Ontario Centre of Innovation programs
TorontoPre-Seed–Growth
3 people
Oquirrh Ventures
Salt Lake CityGrowth–Late Stage$10M – $50M
6 people
Inventures Investment Partners
BrusselsSeed–Growth$270K – $1.1M
8 people
CapMan
HelsinkiSeries A–Late Stage$2.2M – $64.8M
4 people
Altered Capital
AucklandSeries A–Late Stage
12 people
Beltrae Partners
BelfastSeed–Growth$1M – $15M
9 people
MATR Ventures
MiamiSeed–Growth$300K – $5M
9 people
Related lists
Growth Investors & VC Firms (4757)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Enterprise Software Growth Investors & VC Firms (1186)
Data sourced from public filings and firms' own websites — see our methodology.























































